ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1775

Fn14 Deficiency Protects Lupus-Prone Mice from Cutaneous Lesions Induced By Ultraviolet B (UVB) Irradiation

Jessica Doerner1, Adam Friedman2, Linda Burkly3 and Chaim Putterman4, 1Albert Einstein College of Medicine, Bronx, NY, 2Department of Dermatology, George Washington School of Medicine and Health Sciences, Washington, DC, 3Biogen Idec, Cambridge, MA, 4The Division of Rheumatology, Albert Einstein College of Medicine, Bronx, NY

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: cutaneous lupus, cytokines and inflammation

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Systemic Lupus Erythematosus - Animal Models Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Sunlight, via ultraviolet B (UVB) irradiation, is a well-recognized trigger of cutaneous lupus erythematosus (CLE) skin lesions. TNF-like weak inducer of apoptosis (TWEAK), a TNF superfamily member (TNFRSF12), is a soluble cytokine that binds to its sole known signaling receptor, Fn14 (TNFRSF12A). TWEAK and Fn14 are upregulated following tissue inflammation and/or injury, and this signaling pathway is important in critical biologic processes including angiogenesis, cell survival, and local inflammation. Both TWEAK/Fn14 and UVB promote apoptosis and induce the production of proinflammatory cytokines; we wanted to investigate the potential synergism between these two pathways in lupus-associated skin disease by investigating the effects of UVB on lupus-prone mice with or without Fn14.

Methods: To evaluate a possible role for UVB in the pathogenesis of CLE, we exposed female lupus-prone MRL/lpr Fn14 wild type (WT) (n=14) and knockout (KO) mice (n=15) at 14-15 weeks of age to UVB irradiation (2 doses of 50 mJ/cm2 each, 24 hours apart), and evaluated the severity of skin lesions 24 hours after the last dose. Histology was scored using a numerical system, and skin sections were stained and scored for infiltrating macrophages using IBA-1 immunofluorescence. Additionally, snap-frozen skin was analyzed by RT-PCR for inflammatory cytokine expression.

Results: MRL/lpr Fn14 WT mice developed significantly more severe skin involvement following exposure to UVB when compared to strain, age, and gender matched Fn14 KO mice (mean skin score: MRL/lpr Fn14 WT=3.8±0.4, MRL/lpr Fn14 KO=2.5±0.3, p-value=0.01). Histologically, MRL/lpr Fn14 WT mice had significantly more apoptotic keratinocytes and basement membrane degeneration. MRL/lpr Fn14 WT mice also had increased dermal infiltration by macrophages following UVB (MRL/lpr Fn14 WT=5.1±0.3, MRL/lpr Fn14 KO=3.3±0.3, p-value=0.0002). RT-PCR revealed higher levels of skin expression of CXCL10 (MRL/lpr Fn14 WT=5.5±1.0, MRL/lpr Fn14 KO=2.3±1.0 p-value=0.06) and RANTES (MRL/lpr Fn14 WT=6.8±1.3, MRL/lpr Fn14 KO=1.2±0.3, p-value=0.004) in MRL/lpr Fn14 WT as compared to MRL/lpr Fn14 KO mice.

Conclusion: UVB-induced skin inflammation is significantly attenuated in Fn14 deficient MRL/lpr lupus-prone mice. Our data suggests a novel role for the TWEAK/Fn14 signaling pathway in the induction of cutaneous lupus lesions following exposure to UVB irradiation.


Disclosure: J. Doerner, None; A. Friedman, None; L. Burkly, Biogen Idec, 3; C. Putterman, Biogen Idec, 2.

To cite this abstract in AMA style:

Doerner J, Friedman A, Burkly L, Putterman C. Fn14 Deficiency Protects Lupus-Prone Mice from Cutaneous Lesions Induced By Ultraviolet B (UVB) Irradiation [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/fn14-deficiency-protects-lupus-prone-mice-from-cutaneous-lesions-induced-by-ultraviolet-b-uvb-irradiation/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/fn14-deficiency-protects-lupus-prone-mice-from-cutaneous-lesions-induced-by-ultraviolet-b-uvb-irradiation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology